Ferozsons Laboratories Limited (PSX:FEROZ)

Ferozsons Laboratories Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	567.08	551.06	569.05	415.83	830.51	151.39
Short-Term Investments	248.59	-	-	-	-	-
Trading Asset Securities	1,547	496.5	544.97	2,036	1,940	760.71
Cash & Short-Term Investments	2,363	1,048	1,114	2,452	2,771	912.1
Cash Growth	64.92%	-5.96%	-54.57%	-11.51%	203.81%	-19.48%
Accounts Receivable	3,116	2,417	1,123	1,140	1,540	1,093
Other Receivables	235.14	283.81	259.9	432.11	23.37	39.27
Receivables	3,351	2,700	1,383	1,572	1,563	1,132
Inventory	5,875	4,978	5,196	3,260	2,107	2,116
Prepaid Expenses	-	11.84	7.05	1.15	0.42	0.92
Other Current Assets	1,069	1,046	833	468.26	629.81	716.87
Total Current Assets	12,657	9,783	8,533	7,754	7,071	4,877
Property, Plant & Equipment	11,649	11,828	7,975	6,113	4,792	3,996
Other Intangible Assets	32.37	41.04	1.55	1	0.64	0.42
Other Long-Term Assets	97.16	96.98	93.92	93.92	93.92	93.71
Total Assets	24,436	21,750	16,603	13,962	11,958	8,967
Accounts Payable	3,546	1,125	2,716	1,657	1,354	998.52
Accrued Expenses	47.02	897.6	539.82	611.89	615.99	371.47
Short-Term Debt	2,052	2,743	1,261	492.52	-	51.02
Current Portion of Long-Term Debt	389.64	333.07	379.88	141.69	181.53	28.32
Current Unearned Revenue	381.58	471.27	251.96	200.95	79.89	34.72
Other Current Liabilities	99.12	514.79	343.17	282.76	287.6	309.02
Total Current Liabilities	6,515	6,085	5,491	3,387	2,519	1,793
Long-Term Debt	1,828	1,844	1,841	1,537	957.1	95.07
Long-Term Unearned Revenue	382.06	476.91	531.88	331.33	174.13	4.68
Long-Term Deferred Tax Liabilities	1,500	1,524	375.36	408.64	415.23	426.23
Total Liabilities	10,225	9,929	8,240	5,664	4,066	2,319
Common Stock	434.69	434.69	434.69	362.24	362.24	301.87
Retained Earnings	8,137	7,040	6,290	6,100	5,713	4,645
Comprehensive Income & Other	3,598	3,754	1,193	1,305	1,398	1,474
Total Common Equity	12,170	11,228	7,918	7,768	7,473	6,421
Minority Interest	2,042	591.88	445.45	530.68	419.17	227.89
Shareholders' Equity	14,211	11,820	8,364	8,298	7,892	6,648
Total Liabilities & Equity	24,436	21,750	16,603	13,962	11,958	8,967
Total Debt	4,269	4,920	3,482	2,171	1,139	174.41
Net Cash (Debt)	-1,907	-3,872	-2,368	280.9	1,632	737.7
Net Cash Growth	-	-	-	-82.79%	121.28%	-33.70%
Net Cash Per Share	-43.86	-89.08	-54.47	6.46	37.55	16.97
Filing Date Shares Outstanding	43.47	43.47	43.47	43.47	43.47	43.47
Total Common Shares Outstanding	43.47	43.47	43.47	43.47	43.47	43.47
Working Capital	6,142	3,698	3,042	4,367	4,552	3,084
Book Value Per Share	279.96	258.31	182.16	178.70	171.92	147.70
Tangible Book Value	12,137	11,187	7,917	7,767	7,473	6,420
Tangible Book Value Per Share	279.21	257.36	182.12	178.67	171.91	147.69
Land	-	1,691	849.15	849.15	849.15	849.15
Buildings	-	2,013	1,117	1,048	1,028	1,014
Machinery	-	5,077	3,363	2,980	2,660	2,470
Construction In Progress	193.59	3,708	4,160	2,337	1,011	97.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.